The HIV 1 & 2 ELISA test is a serological test that detects antibodies to HIV-1 and HIV-2 in a person's blood.
The Human Immunodeficiency Virus (HIV) is a viral infection that attacks the immune system, specifically targeting CD4 cells (T cells), which are crucial for fighting infections. If left untreated, HIV can lead to Acquired Immunodeficiency Syndrome (AIDS), a condition characterized by severe immune system compromise. Early detection and treatment of HIV are critical for improving health outcomes and preventing transmission. The HIV 1 & 2 ELISA (Enzyme-Linked Immunosorbent Assay) test in Pune is one of the primary screening methods used to detect the presence of HIV antibodies in the blood.
1] Early Detection: The test can identify HIV infection typically within 3 to 12 weeks after exposure, making it a valuable tool for early diagnosis.
2] Large Scale Screening: The ELISA test is suitable for mass screening, enabling public health initiatives to identify and manage HIV in populations.
3] Baseline for Treatment: A positive ELISA result prompts further confirmatory testing and helps healthcare providers establish a baseline for treatment.
4] Monitoring Public Health: Widespread use of the test assists in monitoring the prevalence of HIV in various communities, informing public health policies.
1] Positive Result: Indicates the presence of antibodies to HIV-1 and/or HIV-2, suggesting an active infection. However, a positive ELISA test is not definitive; it must be confirmed with additional testing, typically a Western blot or an HIV RNA test in Delhi.
2] Negative Result: Suggests no detectable antibodies to HIV. However, if exposure occurred recently, it is advisable to retest after a window period (typically 3 months) to account for the time it takes for antibodies to develop.
3] Indeterminate Result: Sometimes, results may be inconclusive. This requires additional testing and consultation with a healthcare provider.
1] Timing of Exposure: Testing too soon after potential exposure may yield false-negative results due to the window period.
2] Co-infections: The presence of other infections or autoimmune disorders can sometimes interfere with test accuracy.
3] Technical Variability: Different laboratories may have varying methodologies, which can affect result interpretation.
4] Medications: Certain medications, such as immunosuppressants, may impact antibody production and result in false negatives.
You should choose Diagnopein for your HIV 1&2 (Human Immunodeficiency Virus) 1&2: ELISA test because we are committed to providing high-quality diagnostic care in a clean and hygienic environment. Our center is equipped with advanced technology to ensure accurate and reliable test results, which are crucial for assessing this test. Diagnopein’s experienced staff is dedicated to handling tests with precision and care, offering you both expertise and comfort. We also offer affordable pricing, making essential health diagnostics accessible without compromising quality. For timely, professional, and affordable cardiac testing, Diagnopein is your trusted partner for your healthcare.
1. HIV-DUO (IV th Generation test) (Serum,CMIA)
2. HIV
3. HIV II
It is crucial for early detection of HIV, enabling timely treatment, reducing transmission risk, and monitoring public health trends.
The test uses enzyme-linked antibodies that bind to HIV antibodies in the blood. If these antibodies are present, a color change occurs, indicating a positive result.
Yes, many health organizations recommend routine testing for individuals at risk, and it may also be included in regular health check-ups.
While there is no cure, antiretroviral therapy (ART) can effectively manage the virus, improve health, and reduce the risk of transmission.